Modus Therapeutics Holding AB (publ) (FRA:99Z)

Market Cap	4.09M -12.3%
Revenue (ttm)	n/a
Net Income	-1.73M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0210
Previous Close	0.0216
Day's Range	0.0210 - 0.0210
52-Week Range	0.0132 - 0.3340
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About FRA:99Z

Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. It develops Sevuparin, a lipopolysaccharide in Phase IIa trial to treat patients with sepsis, septic shock, anemia associated with chronic kidney disease, endotoxemia, severe malaria, and other diseases involving severe systemic inflammation. Modus Therapeutics Holding AB (publ) was founded in 2011 and is headquartered in Stockholm, Sweden.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2011
• Employees: 2
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 99Z

Financial Performance

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 26, 2026

Data Sources Report a data error